EMA confirms path for Diurnal's Chronocort despite trial failure

12th April 2019 Uncategorised 0

The company is on track to submit a Marketing Authorisation Application in the fourth quarter of 2019.

More: EMA confirms path for Diurnal's Chronocort despite trial failure
Source: News